FDA NEWS

FDA to allow irradiation of spinach and lettuce - Chicago Tribune
The controversial practice of irradiating food to kill microorganisms such as E. coli and salmonella can now be used on spinach and lettuce. The Food and Drug Administration has previously approved irradiation on beef, eggs, poultry, oysters and
Source: www.chicagotribune.com

Indian Pharma Ranbaxy Slammed by FDA - BusinessWeek
Drug companies hoping to outsource production to low-cost locations in India are probably following closely the news about Ranbaxy Laboratories, arguably India’s premier drugmaker and a big seller of generic drugs in the U.S. and other markets. A
Source: www.businessweek.com

FDA Tests Gilead's Patience - Forbes
Gilead Sciences had a minor setback this week, but it's nothing that the company can't handle, analysts said. The Foster City, Calif.-based pharmaceutical company said it received a letter from the U.S. Food and Drug Administration asking for more
Source: www.forbes.com

Ranbaxy Shaken By FDA Action - Forbes
Ranbaxy Laboratories responded with shock Wednesday to the U.S. Food and Drug Administration's actions to limit the importation of its drugs into the U.S. "Ranbaxy is very disappointed in the action FDA has taken. The company has responded to each
Source: www.forbes.com

Mylan shares rise as rival Ranbaxy gets FDA ban - BusinessWeek
Shares of drug developer Mylan Inc. jumped Wednesday following the Food and Drug Administration's move to ban imports from the company's generic competitor Ranbaxy Laboratories. Pittsburgh-based Mylan's stock picked up 71 cents, or 6.6 percent, to
Source: www.businessweek.com

FDA: India's Generic Drug Giant Imports Blocked - Time
(WASHINGTON) — The government closed U.S. borders Tuesday to more than 30 generic drugs — including popular antibiotics and cholesterol medicines — made by India's biggest pharmaceutical company, citing poor quality in two of its factories. The
Source: www.time.com

Gilead Cystic Fibrosis Drug Rejected by FDA - Street.Com
Gilead Sciences ( GILD Quote - Cramer on GILD - Stock Picks ) said late Tuesday that U.S. regulators refused to approve the company's experimental cystic fibrosis drug. The Food and Drug Administration issued Gilead a complete response letter for
Source: www.thestreet.com

Ranbaxy vows to resolve U.S. import ban on generics - San Diego Union-Tribune
MUMBAI, India – India's largest pharmaceutical company, Ranbaxy Laboratories, said Wednesday that it will resolve problems that led the U.S. Food and Drug Administration to ban the import of more than 30 of its generic drugs. On Tuesday, the FDA
Source: www.signonsandiego.com